Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jan;31(1):3-9.
doi: 10.1097/ICU.0000000000000626.

Management of cataract in the setting of uveitis: a review of the current literature

Majid Moshirfar  1 , Anisha N Somani, Mahsaw N Motlagh, Yasmyne C Ronquillo
Affiliations
Review

Management of cataract in the setting of uveitis: a review of the current literature

Majid Moshirfar et al. Curr Opin Ophthalmol. 2020 Jan.

Abstract

Purpose of review: This review aims to cover the preoperative planning, intraoperative considerations, and postoperative management that aids in successful outcomes of patients with cataract and uveitis. Disease-specific management and pediatric management will also be addressed.

Recent findings: Dexamethasone implants appear to be a safe and effective addition to standard steroid treatment in decreasing the incidence of postoperative cystoid macular edema (CME). Intravitreal steroids and topical difluprednate have shown utility in CME treatment.

Summary: Cataract surgery in eyes with uveitis is generally safe and effective if inflammation is well controlled; however, complication rates are still higher than in eyes without uveitis. Future investigations should delineate outcomes for eyes with different etiologies of uveitis, and further research is needed to adequately control inflammation and avoid postoperative complications.

PubMed Disclaimer

References

    1. AlBloushi AF, Alfawaz AM, Al-Dahmash SA, et al. Incidence, risk factors and surgical outcomes of cataract among patients with uveitis in a university referral hospital in Riyadh, Saudi Arabia. Ocul Immunol Inflamm 2018; 24:1–9.